Twist Bioscience prices upsized USD 300 million common stock offering at USD 96 per share
TWST•Upsized follow-on offering priced
Twist Bioscience priced an upsized underwritten follow-on offering of 3,125,000 common shares at USD 96 per share.
- Gross proceeds are expected to be USD 300 million.
- Closing is targeted for Aug. 6, 2026, subject to customary conditions.
- Underwriters have a 30-day option to buy up to 468,750 additional shares at the offering price, less discounts and commissions.
- Proceeds are earmarked for R&D, manufacturing expansion, product offerings, working capital, and general corporate purposes.
